Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancer
Andrew W. McPherson,Ignacio Vazquez-Garcia,Matthew A. Myers,Matthew Zatzman,Duaa H. Al-Rawi,Adam C. Weiner,Samuel S Freeman,Neeman Mohibullah,Gryte Satas,Marc J. Williams,Nicholas Ceglia,Allen W. Zhang,Jun Li,Jamie L.P. Lim,Michelle Wu,Seongmin Choi,Eliyahu Havasov,Diljot Grewal,Hongyu Shi,Minsoo Kim,Roland F Schwarz,Tom L. Kaufmann,Khanh N. Dinh,Florian Uhlitz,Julie Tran,Yushi Wu,Ruchi Patel,Satish Ramakrishnan,DooA Kim,Justin Clarke,Hunter Green,Emily Ali,Melody DiBona,Nancy Varice,Ritika Kundra,Vance Broach,Ginger J. Gardner,Kara Long Roche,Yukio Sonoda,Oliver Zivanovic,Sarah H. Kim,Rachel N. Grisham,Ying L. Liu,Agnes Viale,Nicole Rusk,Yulia Lakhman,Lora H. Ellenson,Simon Tavare,Samuel AJR Aparicio,Dennis S. Chi,Carol Aghajanian,Nadeem R. Abu-Rustum,Claire F. Friedman,Dmitriy Zamarin,Britta Weigelt,Samuel F. Bakhoum,Sohrab P. Shah
DOI: https://doi.org/10.1101/2024.07.11.602772
2024-07-15
Abstract:Whole-genome doubling (WGD) is a critical driver of tumor development and is linked to drug resistance and metastasis in solid malignancies. Here, we demonstrate that WGD is an ongoing mutational process in tumor evolution in cancers with TP53 loss. Using single-cell whole-genome sequencing, we measured and modeled how WGD events are distributed across cellular populations within tumors and associated WGD dynamics with properties of genome diversification and phenotypic consequences of innate immunity. We studied WGD evolution in 65 high-grade serous ovarian cancer (HGSOC) tissue samples from 40 patients, yielding 29,481 tumor cell genomes. We found near-ubiquitous evidence of WGD as an ongoing mutational process promoting cell-cell diversity, high rates of chromosomal missegregation, and consequent micronucleation. Using a novel mutation-based WGD timing method, doubleTime, we delineated specific modes by which WGD can drive tumor evolution: (i) unitary evolutionary origin followed by significant diversification, (ii) independent WGD events on a pre-existing background of copy number diversity, and (iii) evolutionarily late clonal expansions of WGD populations. Additionally, through integrated single-cell RNA sequencing and high-resolution immunofluorescence microscopy, we found that inflammatory signaling and the positive association between chromosomal instability and cGAS-STING pathway activation are restricted to tumors that remain predominantly diploid. This contrasted with predominantly WGD tumors, which exhibited significant quiescent and immunosuppressive phenotypic states. Together, these findings establish WGD as an evolutionarily 'active' mutational process in late stage ovarian cancer and link consequent genomic states with altered innate immune responses and immunosuppressive phenotypes.
Cancer Biology